Gout in African Americans
1Department of Medicine, Stanford University School of Medicine, Palo Alto, Calif.
Insights
African Americans have a lower risk of developing gout and hyperuricemia compared to Caucasians, even after accounting for common risk factors. This finding challenges previous assumptions about gout prevalence in different ethnic groups.
Area of Science:
- Epidemiology
- Cardiovascular Health
- Rheumatology
Background:
- Gout risk factors are more prevalent in African Americans than Caucasians.
- Previous studies suggest higher gout incidence in African Americans.
Purpose of the Study:
- To compare the risk for incident gout between African American and Caucasian men.
- To investigate ethnic disparities in gout incidence.
Main Methods:
- Analysis of gout incidence in 11,559 Caucasian and 931 African American men (aged 35-57) from the Multiple Risk Factor Intervention Trial.
- Seven-year observation period with Cox regression models to adjust for confounding factors like BMI, hypertension, diabetes, and kidney disease.
Main Results:
- African Americans had a 14% lower prevalence of hyperuricemia at baseline.
- After adjusting for risk factors, African American ethnicity was associated with a lower hazard ratio for gout (0.78) and hyperuricemia (0.88).
- Ethnic disparities were most pronounced in individuals without other gout risk factors.
Conclusions:
- African American ethnicity is linked to a significantly lower risk of gout and hyperuricemia compared to Caucasian ethnicity, after controlling for risk factor prevalence.
- Findings indicate a need to re-evaluate ethnic disparities in gout epidemiology.
Purpose:
African Americans have a substantially higher prevalence of risk factors for gout than Caucasians. The aim of the present study was to compare the risk for incident gout among African Americans and Caucasians.
Methods:
Incidence rates of physician-diagnosed gout among 11,559 Caucasian men and 931 African American men aged 35 to 57 years and at high cardiovascular risk, observed for 7 years as a part of the Multiple Risk Factor Intervention Trial, were analyzed. Cox regression models were used to account for potential confounding by age, body mass index, diuretic use, hypertension and diabetes status, aspirin and alcohol consumption, and kidney disease.
Results:
At baseline, after accounting for risk factors, African Americans had a 14% lower prevalence of hyperuricemia than Caucasians. Incidence of gout increased with increasing prevalence of risk factors in both Caucasians and African Americans. Ethnic disparities in incidence rates were most apparent among those without other risk factors for gout. In separate Cox regression models, after accounting for risk factors, African American ethnicity was associated with a hazard ratio of 0.78 (95% confidence interval [CI], 0.66-0.93) for physician-diagnosed gout and 0.88 (95% CI, 0.85-0.90) for incident hyperuricemia. Significant interactions were observed; the association was the strongest (hazard ratio 0.47; 0.37-0.60). These associations were unaffected by addition of serum urate as a covariate or by using alternate case definitions for gout.
Conclusions:
After accounting for the higher prevalence of risk factors, African American ethnicity is associated with a significantly lower risk for gout and hyperuricemia compared with Caucasian ethnicity.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Chronic Kidney Disease II: Clinical Manifestations
Principles of Pharmacogenetics: Types of Genetic Variants
Diabetic Nephropathy
Complications of Diabetes Mellitus
Diabetic Foot Ulcer


